Thymoma

Thymoma is most commonly observed in individuals aged between forty and sixty years. Approximately 10% to 15% of cases are classified as malignant. While nearly 80% of thymomas are benign, they can still impact the daily lives of patients. As the tumor grows, it may exert pressure on surrounding structures, leading to symptoms such as chest tightness, chest pain, shortness of breath, and cough. In severe cases, the tumor may compress the superior vena cava, affecting venous return from the face and head and neck regions, which can result in facial swelling or damage to the vocal cords.

Patients with thymoma often experience accompanying symptoms, such as myasthenia gravis (MG), which can cause drooping eyelids, double vision, and weakness in the muscles responsible for swallowing, speaking, and breathing. Additionally, patients may develop other autoimmune disorders, such as glomerulonephritis and certain erythrocyte developmental disorders.

Due to the potential for thymomas to worsen, the most effective treatment method is complete surgical resection. Prior to surgery, CT scans and positron emission tomography (PET) scans can be utilized to determine the location of the thymoma and assess any invasion into surrounding tissues or potential spread. This approach allows for the development of a surgical plan without the need for a tissue biopsy, as the thymus does not serve a significant function in adults, making resection a reasonable choice.

The surgical plan depends on the tumor's location and characteristics. If the thymoma is located behind the sternum or adjacent to critical structures and requires vascular reconstruction, traditional open chest surgery may be necessary. However, if the tumor is relatively mobile, robotic-assisted minimally invasive surgery can be considered, as it expands the surgical field and allows for precise manipulation, thereby reducing damage to surrounding tissues, enhancing surgical safety, and decreasing the risk of complications.

Even if the surgery is successful, patients should undergo regular check-ups, particularly for those with higher-stage cases, where postoperative adjuvant therapy is typically recommended to reduce the risk of recurrence. For patients with lower-stage tumors, while postoperative treatment may not be necessary, regular CT scans are still advised to monitor disease progression.

Thymoma is a rare yet significant health concern that requires careful monitoring and treatment. With advancements in surgical techniques and ongoing research into effective therapies, patients diagnosed with thymoma can anticipate improved prognoses and quality of life. Regular check-ups and proactive management are essential for ensuring long-term health after treatment.